Uliginosina B é um derivado acilfloroglucinol natural, isolado de espécies de Hypericum nativas da América do Sul. Estudos prévios demonstraram que a uliginosina B apresenta efeitos do tipo antidepressivo e antinociceptivo em baixas doses (até 15 mg/kg, i.p. ou v.o.) e, em doses elevadas (90 mg/kg, i.p.), prejudica a coordenação motora. A atividade antidepressiva depende da ativação da neurotransmissão monoaminérgica e envolve a regulação da homeostase através do balanço de Na+. A atividade antinociceptiva é mediada por receptores opioides e dopaminérgicos da família D2. O efeito atáxico depende da ativação de receptores opioides e dopaminérgicos. Os efeitos parecem ser decorrentes da sua capacidade de inibir a recaptação de monoaminas (especialmente dopamina) com consequente ativação de receptores opioides e monoaminérgicos. O objetivo deste estudo foi aprofundar o conhecimento sobre o mecanismo de ação antinociceptiva de uliginosina B, investigando o envolvimento da neurotransmissão monoaminérgica, glutamatérgica e purinérgica. O tratamento com uliginosina B aumentou a disponibilidade intersticial de dopamina e seu metabólito, ácido homovanílico (HVA), no estriado de ratos; dados que reforçam o papel da neurotransmissão dopaminérgica nos efeitos da uliginosina B. O papel das outras monoaminas e da neurotransmissão glutamatérgica foi investigado nos efeitos antinociceptivo e atáxico induzidos por uliginosina B. A ataxia (90 mg/kg, i.p.) foi completamente prevenida pelo tratamento prévio com pCPA (inibidor da síntese de serotonina) e MK-801 (antagonista do receptor glutamatérgico NMDA), mas não foi afetada pelo prétratamento com prazosina ou ioimbina (antagonistas de receptores adrenérgicos α1 e α2, respectivamente). A atividade antinociceptiva (15 e 90 mg/kg, i.p.) foi reduzida significativamente pelo pré-tratamento com pCPA e MK-801 e aumentada pelo prétratamento com prazosina e ioimbina, apenas na dose mais elevada (90 mg/kg, i.p.). A importância da neurotransmissão monoaminérgica para o efeito antinociceptivo da uliginosina B foi confirmada através da análise isobolar. A associação de uliginosina B com amitriptilina (inibidor da recaptação de monoaminas) ou clonidina (agonista adrenérgico α2) apresentou interação aditiva – dados sugestivos de substâncias com mecanismos de ação mediados pelas mesmas vias – enquanto a associação com morfina (agonista opioide) apresentou interação sinérgica – dados indicativos de um possível uso clínico, como adjuvante opioide na farmacoterapia da dor. O efeito antinociceptivo de uliginosina B (15 mg/kg, i.p.) também foi prevenido pelo tratamento prévio com DPCPX e ZM-241385 (antagonistas de receptores adenosinérgicos A1 e A2A, respectivamente). Este efeito esta relacionado, pelo menos em parte, com a capacidade da uliginosina B aumentar a hidrólise de AMP na medula espinhal e de ATP no córtex cerebral. A uliginosina B também inibiu in vitro a atividade da enzima Na+,K+-ATPase (isoformas α1 e α3). O conjunto de dados apresentados nesta tese evidencia a uliginosina B como um padrão estrutural multirreceptor promissor no desenvolvimento de fármacos com ação analgésica. Em suma, os efeitos antinociceptivo e atáxico induzidos pelo tratamento com uliginosina B são mediados pela ativação da neurotransmissão monoaminérgica, glutamatérgica, purinérgica e opióide, requisitadas com diferente grau de importância; e ainda envolvem o balaço iônico da Na+,K+-ATPase. / Uliginosin B is a natural acylphloroglucinol derivative obtained from Hypericum species native to South America. Previous studies have shown that uliginosin B presents antidepressant-like and antinociceptive effects at low doses (up to 15 mg/kg, i.p. or p.o.), and at high doses (90 mg/kg, i.p.) it impairs the motor coordination. The antidepressant-like activity seems to depend on the activation of monoaminergic neurotransmission and ionic balance of Na+. The antinociceptive effect is mediated by opioid and D2 dopamine receptors. The ataxic effect involves opioid and dopaminergic receptors activation. The uliginosin B effects appear to be a consequence of their ability to inhibit reuptake of monoamines (especially dopamine) with subsequent activation of opioid and monoaminergic receptors. The aim of this study was to deepen our knowledge about the mechanism of antinociceptive action of uliginosin B, investigating the involvement of monoaminergic, glutamatergic and purinergic neurotransmissions. Treatment with uliginosin B increased the interstitial availability of dopamine and its metabolite, homovanillic acid (HVA), in the striatum of rats; these data underscore the role of dopaminergic neurotransmission in the effects of uliginosin B. The role of other monoamines as well as the glutamatergic neurotransmission, were investigated in the antinociceptive and ataxic effects induced by uliginosin B. The ataxic effect (90 mg/kg, i.p.) was completely prevented by pre-treatment with pCPA (a serotonin synthesis inhibitor) and MK-801 (a NMDA glutamatergic receptor antagonist), but was not affected by pretreatment with prazosin or yohimbine (α1 and α2 adrenoceptor antagonists, respectively). The antinociceptive activity (15 and 90 mg/kg, i.p.) was significantly reduced by pretreatment with pCPA and MK-801 and increased by pretreatment with yohimbine and prazosin only at the highest dose (90 mg/kg, i.p.). The importance of monoaminergic neurotransmission for the uliginosin B antinociceptive effect was confirmed by isobolar analysis. The association between uliginosin B with amitriptyline (monoamine reuptake inhibitor) or clonidine (α2 adrenergic agonist) showed additive interaction - findings suggestive of substances with mechanisms of action mediated by the same pathways - while the association with morphine (opioid agonist) showed synergistic interaction - indicative of a possible clinical use as adjuvant to opioid pharmacotherapy of pain relief. The antinociceptive effect of uliginosin B (15 mg/kg, i.p.) was also prevented by pretreatment with DPCPX and ZM-241385 (A1 and A2A adenosinergic receptor antagonists, respectively). This effect is related, at least in part, to its ability of increases the AMP and ATP hydrolysis in the spinal cord and cerebral cortex synaptosomes, respectively. Moreover, uliginosin B inhibited the Na+,K+-ATPase activity (α1 and α3 isoforms) in vitro. The data set presented in this thesis pointed uliginosin B as a promising multirreceptor molecular pattern in the analgesic drug development. In summary, the antinociceptive and ataxic effects induced by uliginosin B were mediated by the activation of monoaminergic, glutamatergic, purinérgico and opioid neurotransmission and involves the ionic balance, required with different degree of importance.

Trichomonas vaginalis é o agente etiológico da doença sexualmente transmissível não viral mais comum no mundo, sendo registrados aproximadamente 276 milhões de novos casos de tricomonose a cada ano. O estabelecimento da infecção se deve principalmente à capacidade de adesão do parasito às células epiteliais vaginais, cervicais ou de próstata, seguida pela intensa reação inflamatória, resultado da infiltração de neutrófilos no sítio da infecção. Nucleotídeos e nucleosídeos, especialmente ATP e adenosina, são liberados para o espaço extracelular por células em situações de estresse ou injúria tecidual e desenvolvem seus efeitos sinalizadores através da ativação de purinoceptores. Ainda, as ectonucleotidases, NTPDase e ecto-5’-nucleotidase, são capazes de hidrolisar os nucleotídeos gerando adenosina e finalmente, a enzima adenosina deaminase (ADA) é responsável pela conversão de adenosina em inosina. A expressão gênica de cinco NTPDases putativas presentes no genoma de T. vaginalis foram investigadas, assim como o envolvimento da sinalização purinérgica na relação parasito-hospedeiro. Nossos resultados mostraram que diferentes isolados de T. vaginalis expressam os genes TvNTPDase1, 2, 3, 4 e 5, sendo observado o maior número de transcritos para TvNTPDase1, 2 e 4. A sequência preditiva de aminoácidos revelou a presença das cinco regiões conservadas da apirase, domínios transmembrana, sítios de fosforilação, peptídeos sinais e os prováveis sítios ativos da enzima. A análise filogenética demonstrou maior similaridade das TvNTPDases com as formas intracelulares da enzima, como as NTPDases 4 e 7 humanas e a de Saccharomyces cerevisiae. Além disso, a restrição de soro promoveu aumento significativo da atividade da NTPDase de T. vaginalis, no entanto sem corresponder com o aumento de expressão gênica de determinada(s) sequência(s). Quanto à participação da sinalização purinérgica na resposta inflamatória de células do hospedeiro frente ao parasito, foram utilizados como modelos celulares as células epiteliais vaginais (HMVII), cervicais (HeLa) e neutrófilos humanos. As linhagens HMVII e HeLa mostraram expressar todos os subtipos de receptores P1, P2X e P2Y e XI os diferentes isolados de T. vaginalis, que foram cocultivados com as células, mostraram hidrolisar eficientemente os nucleotídeos ATP, ADP e AMP. Ainda, o isolado clínico fresco TV-LACM6 foi o único a apresentar elevada citotoxicidade frente às células epiteliais vaginais e cervicais, no entanto não foi detectado aumento da liberação de ATP pelas células após o cocultivo, provavelmente devido à alta atividade da enzima NTPDase observada nesse isolado. Os trofozoítos de T. vaginalis não foram capazes de aumentar a produção de IL-8 e IL-6 pelas linhagens HMVII e HeLa, e apenas os isolados ATCC30236 e TV-LACM6 causaram aumento na secreção da citocina MIP-3α pelas células epiteliais cervicais. Finalmente, o nucleotídeo ATP e o nucleosídeo adenosina não modularam a produção dos mediadores inflamatórios investigados. Em relação aos neutrófilos, estes mostraram aumentar a produção de espécies reativas de oxigênio (ERO) e IL-8 após incubação com os trofozoítos de T. vaginalis. Os nucleotídeos e nucleosídeos da adenina e guanina não produziram efeito na produção de ERO e IL-8; no entanto, quando o nucleosídeo adenosina foi incubado junto com o inibidor da enzima ADA (EHNA) observou-se uma redução significativa da produção de ERO e IL-8 pelos neutrófilos, devido à inibição da ADA e consequentemente, ao aumento da concentração de adenosina disponível no meio extracelular. Os nossos resultados indicaram a ativação do receptor A1 dos neutrófilos nessa condição. O conjunto de dados aqui obtidos contribuiu para uma melhor caracterização da família de enzimas NTPDases de T. vaginalis assim como para um maior conhecimento acerca da influência da sinalização purinérgica na relação parasito-hospedeiro. / Trichomonas vaginalis is the agent of the most common non-viral sexually transmitted disease worldwide, causing 276.4 million new cases a year. The establishment of the infection is closely related to the parasite ability to adhere to vaginal, cervical and prostate epithelial cells, followed by an intense inflammatory response as result of neutrophil infiltration. Nucleotides and nucleosides, mainly ATP and adenosine, are released into the extracellular space by cells under stress or injury and they exert their signaling effects through activation of the purinoceptors. Moreover, the ectonucleotidases, NTPDase and ecto-5'-nucleotidase, are capable of hydrolyzing the nucleotides producing adenosine and finally, the adenosine deaminase (ADA) is responsible for the conversion of adenosine to inosine. We investigated the gene expression of five putative NTPDases found in T. vaginalis genome as well as the involvement of purinergic signaling on the host-parasite relationship. Our results showed that different T. vaginalis isolates are able to express TvNTPDase1, 2, 3, 4 and 5 and that TvNTPDase1, 2 and 4 are the most expressed genes. Predictive amino acid sequence revealed the presence of the five apyrase conserved regions, transmembrane domains, phosphorylation sites, signal peptides and the active sites. Phylogenetic analysis showed that TvNTPDases share more similarity with the intracellular enzymes, such as human NTPDase 4 and 7 and Saccharomyces cerevisiae NTPDase. In addition, the serum limitation caused a significant increase in NTPDase activity, but without association with the gene expression of a specific TvNTPDase sequence. Regarding the participation of purinergic signaling on the inflammatory responses against the parasite, the vaginal (HMVII) and cervical (HeLa) epithelial cells and the human neutrophils were used as cellular models. HMVII and HeLa cell lines showed to express all subtypes of P1, P2X and P2Y receptors and the different T. vaginalis isolates, which were co-cultured with the cells, showed to hydrolyze efficiently ATP, ADP and AMP. Furthermore, only the fresh clinical isolate, TV-LACM6, caused a profound cytotoxicity against the vaginal and cervical epithelial cells. Interestingly, it was not detected an increase in ATP release by the cells after cocultivation, probably due to the high NTPDase activity dislplayed by TV-LACM6 isolate. The T. vaginalis trophozoites were not able to increase the production of IL-8 and IL-6 by HMVII and HeLa cells and only ATCC30236 and TV-LACM6 isolates enhanced MIP-3α secretion by the cervical epithelial cells. Finally, neither ATP nor adenosine has modulated the production of the inflammatory mediators here investigated. Considering the neutrophils, T. vaginalis stimulated the production of reactive oxygen species (ROS) and IL-8 by these immune cells and both adenine as guanine nucleotides and nucleosides did not cause any effect on ROS and IL-8 levels. However, when adenosine was incubated with an ADA inhibitor (EHNA) we observed a significant reduction of ROS and IL-8 production by neutrophils, due to inhibition of ADA with a subsequent increase of adenosine concentration in the extracellular milieu. . Our results suggested the participation of A1 receptor in this condition. The data set obtained in this study contributed to the characterization of T. vaginalis NTPDases family as well as to a better understanding of the influence of purinergic signaling on host-parasite relationship.

A Artrite Reumatóide (AR) é uma artropatia autoimune multifatorial com etiologia desconhecida que afeta aproximadamente 1% da população adulta. A estratégia padrão para o tratamento da AR consiste na administração de baixas doses de Metotrexato (MTX), cujo efeito anti-inflamatório está relacionado com a manutenção dos níveis elevados de adenosina (ADO) extracelular. No entanto, uma parte considerável dos pacientes com AR é refratária ao tratamento com MTX e o mecanismo pelo qual este fenômeno ocorre ainda não está totalmente esclarecido. Neste contexto, o presente estudo descreveu que a eficácia terapêutica ao MTX está associada com a expressão em células Tregs da ectoenzima CD39, cuja função biológica é a geração de ADO extracelular via metabolização do ATP. Especificamente, através da realização de um estudo longitudinal, observamos que pacientes respondedores ao MTX (R-MTX) apresentam uma expansão de células Tregs circulantes expressando CD39 após o tratamento com MTX. Por outro lado, identificamos que pacientes não respondedores ao MTX (UR-MTX) possuem uma redução da expressão de CD39 em células Tregs, o que culmina em um comprometimento das suas funções supressoras. Ainda, demonstramos que a expressão de CD39 em células Tregs é um biomarcador apto em predizer a resposta terapêutica ao MTX, visto que pacientes UR-MTX apresentam uma expressão reduzida de CD39 em Tregs mesmo antes do início do tratamento com MTX. Posteriormente, nós investigamos as bases moleculares que acarretam na expressão reduzida de CD39 observada em células Tregs de pacientes URMTX. Demonstramos que a estimulação com TGF-? tanto em células Tregs isoladas quanto diferenciadas in vitro aumenta a expressão de CD39 através da ativação sequencial da seguinte plataforma molecular: receptores de TGF-? (TGFBRII e TGFBRI), transdutor de sinal SMAD2, fator de transcrição CREB, de modo dependente da atividade de p38. Uma vez identificada a via envolvida com a indução da expressão de CD39, demonstramos que células Tregs diferenciadas de indivíduos que apresentam uma expressão reduzida de CD39 são incapazes de induzir a expressão desta ectoenzima através da estimulação com TGF-?. Por fim, transpondo nossos achados para pacientes com AR, observamos que pacientes UR-MTX apresentam uma redução nos níveis de RNAm para TGFBRII e CREB bem como também uma redução das proteínas fosforiladas SMAD2 e CREB em células CD4+ e Tregs, sugerindo que o comprometimento na cascata de sinalização de TGF-?, envolvida com a indução da expressão de CD39 em células Tregs, está associado com a resistência ao MTX. / Rheumatoid arthritis (RA) is an autoimmune multifactorial arthropathy with unknown etiology that affects approximately 1% of the adult population. The standard strategy for RA treatment comprises the administration of low doses of methotrexate (MTX), whose antiinflammatory effects are associated with maintenance of high levels of extracellular adenosine (ADO). However, a considerable proportion of RA patients is resistant to MTX treatment and the mechanisms underlying this phenomenon occurs is poorly understood. Within this context, the present study showed that therapeutic efficacy of MTX is associated with expression on Treg cells of the ectoenzyme CD39, whose function is related to the generation of extracellular ADO by ATP metabolism. Specifically, we conducted a longitudinal study and observed that responsive patients to MTX (R-MTX) exhibit an increase in the frequency of circulating Treg cells expressing CD39 after MTX treatment. On the other hand, we found that non-responsive patients to MTX (UR-MTX) have a reduction of CD39 expression on Treg cells, which culminates in an impairment of Treg function. Furthermore, these findings indicate that CD39 expression on Treg cells is a biomarker for therapeutic response to MTX, since UR-MTX patients had a depressed CD39 expression on Treg cells even before MTX treatment. Subsequently, the present study investigated the molecular mechanisms that would cause the reduction of CD39 expression on Treg cells from UR-MTX patients. For this, we demonstrated that TGF-? stimulation increases CD39 expression in isolated and in vitro differentiated Treg cells through participation/activation of the following molecules: receptors of TGF-?, TGFBRII and TGFBRI, signal transducer SMAD2 and transcription factor CREB, through p38 activity dependent-manner. Once identified these molecules involved with CD39 induction, we demonstrated that differentiated Treg cells from healthy individuals with an intrinsic reduction of CD39 expression on circulating Treg cells are unable to increase CD39 expression by TGF-? stimulation. Transposing our findings to RA patients, we found that UR-MTX patients exhibit a reduction of mRNA for TGFBRII and CREB as well as reduction on levels of phospho-SMAD2 and phospho-CREB in CD4+ and Treg cells, suggesting that an impairment in TGF-? signaling pathway, related to induction of CD39 expression on Treg cells, is associated with MTX resistance.

No description available.

Les nucléotides jouent un rôle majeur dans une pléiade de processus biologiques comme la composition des acides nucléiques, la signalisation, ou la régulation de la balance énergétique. Les nucléotides extracellulaires exercent également des fonctions biologiques. Par conséquent, des dérégulations des pools de nucléotides impactent l’homéostasie de multiples façons, par exemple en promouvant l’instabilité génétique ou un environnement immunosuppresseur. Or, ces paramètres font partie des « Hallmarks du Cancer » décrits par Hanahan et Weinberg. Ces observations confirment l’éventualité d’un rôle clé des nucléotides dans le cadre du cancer.cN-II et CD73 sont des 5’-nucléotidases impliquées respectivement dans les métabolismes nucléotidiques intra- et extracellulaire. Elles sont de nouvelles cibles thérapeutiques en oncologie. Cependant, leurs rôles dans la biologie de la cellule cancéreuse, ou le possible impact de leur utilisation en tant que cible thérapeutique sur le comportement des cellules tumorales sont peu connus. Considérant l’implication de ces enzymes dans les métabolismes nucléotidiques, nous avons enquêté sur les modifications de l’agressivité de la cellule cancéreuse ou sur sa capacité à interagir avec son microenvironnement, dans le cas d’une invalidation ou une diminution d’expression de cN-II et/ou CD73. cN-II semble donc impliquée dans l’adaptabilité métabolique et la combinaison des invalidations de cN-II et CD73 est associée à une modification d’expression d’enzymes du métabolisme du glucose. CD73 peut aussi moduler l’expression de gènes de la migration cellulaire. cN-II est impliquée dans la migration cellulaire, via l’axe COX-2/PGE2, et dans la sensibilité à des agents modulant ce paramètre. Ces caractéristiques sont plus marquées en association avec une invalidation de CD73. Ici, cN-II et CD73 ne semblent pas jouer de rôle dans la prolifération ou le dialogue avec une sous-population de cellule de l’immunité innée / Nucleotides play a major role in nucleic acids constitution and are involved in various cell phenomena. Indeed, intracellular ATP, GTP, AMP, GMP and their cyclic forms are components of cell signaling and define the energetic balance. Extracellularly, they also play multiple roles. Thus, when nucleotide pools are deregulated various processes are impacted. For example, a low availability of nucleotides supports genetic instability and aberrant levels of extracellular adenosine can lead to an immunosuppressive microenvironment. Interestingly, the cited parameters are among the Cancer Hallmarks described by Hanahan and Weinberg. These observations confirm the possibility of a key role of these molecules in this pathology. cN-II and CD73 are 5’-nucleotidases, involved in intra- and extracellular nucleotide metabolism respectively and have been identified as possible targets for new anti-cancer therapies. Nevertheless, very little is known about their biological roles on cancer cells and what parameters of cell biology could be impacted by such strategies. Considering the involvement of these purines in cell metabolism, we wondered what changes a decrease in cN-II and/orCD73 expressions or their silencing could trigger in cancer cells as well as in the interplay with their microenvironment.We studied cancer cell aggressiveness and the interplay with innate immune cells under cN-II and CD73 modulations. We observed that cN-II is involved in metabolic adaptability. The association of cN-II and CD73 invalidations results in glucose-metabolism-related gene modifications. CD73 can regulate migration-related genes expression but does not affect the process. cN-II is also involved in cell migration, via the COX-2/PGE2 axis. Again, these characteristics are accentuated when associated with CD73 deficiency. Here, cN-II and CD73 do not seem to be involved in cancer cell proliferation or in their interplay with a subset of innate immune cells

Diabetes is closely associated with increased oxidative stress, especially originating from the mitochondria. A mechanism to reduce increased mitochondria superoxide production is to reduce the mitochondria membrane potential by releasing protons across the mitochondria membrane. This phenomenon is referred to as mitochondria uncoupling since oxygen is consumed independently of ATP being produced and can be mediated by Uncoupling Proteins (UCPs). However, increased oxygen consumption is potentially detrimental for the kidney since it can cause tissue hypoxia. Therefore, this thesis aimed to investigate the role of mitochondria uncoupling for development of diabetic nephropathy.      UCP-2 was demonstrated to be the only isoform expressed in the kidney, and localized to tubular segments performing the majority of tubular electrolyte transport. Streptozotocin-induced diabetes in rats increased UCP-2 protein expression and correlated to increased non-transport dependent oxygen consumption in isolated proximal tubular cells. These effects were prevented by intense insulin treatment to the diabetic animals demonstrating a pivotal role of hyperglycemia. Importantly, elevated UCP-2 protein expression increased mitochondria uncoupling in mitochondria isolated from diabetic kidneys. Mitochondria uncoupling and altered morphology was also evident in kidneys from db/db-mice, a model of type-2 diabetes, together with proteinuria and glomerular hyperfiltration which are both clinical manifestations of diabetic nephropathy. Treatment with the antioxidant coenzyme Q10 prevented mitochondria uncoupling as well as morphological and functional alterations in these kidneys. Acute knockdown of UCP-2 paradoxically increased mitochondria uncoupling in a mechanism involving the adenosine nucleotide transporter. Increased uncoupling via adenosine nucleotide transporter decreased mitochondria membrane potential and kidney oxidative stress but did not affect glomerular filtration rate, renal blood flow, total kidney oxygen consumption or intrarenal tissue oxygen tension.      The role of increased mitochondria oxygen consumption was investigated by administering the chemical uncoupler dinitrophenol to healthy rats. Importantly, increased mitochondria oxygen consumption resulted in kidney tissue hypoxia, proteinuria and increased staining of the tubular injury marker vimentin, demonstrating a crucial role of increased oxygen consumption per se and the resulting kidney tissue hypoxia for the development of nephropathy.      Taken together, the data presented in this thesis establishes an important role of mitochondria uncoupling for the development of diabetic nephropathy.

All living cells are dependent on nucleic acids for their survival. The genetic information stored in DNA is translated into functional proteins via a messenger molecule, the ribonucleic acid (RNA). Since DNA and RNA can be considered as polymers of nucleotides (NTPs), balanced pools of NTPs are crucial to nucleic acid synthesis and repair. The de novo reduction of ribonucleoside diphosphates (NDPs) to deoxyribonucleoside diphosphates (dNDPs), the precursors for DNA synthesis, is catalyzed by the enzyme ribonucleotide reductase (RNR). In cycling cells the dominant form of mammalian RNR consists of two proteins called R1 and R2. A proteasome-mediated degradation completely deprives postmitotic cells of R2 protein. The nonproliferating cells use instead a p53 inducible small RNR subunit, called p53R2 to synthesize dNTPs for mitochondrial DNA replication and DNA repair. To address the ongoing controversy regarding the localization and subsequently function and regulation of RNR subunits, the subcellular localization of all the mammalian RNR subunits during the cell cycle and after DNA damage was followed as a part of this thesis. Irrespective of the employed methodology, only a cytosolic localization could be observed leading to a conclusion that the dNTPs are synthesized in the cytosol and transported into the nucleus or mitochondria for DNA synthesis and repair. Thus, our data do not support the suggestion that nuclear translocation is a new additional mechanism regulating ribonucleotide reduction in mammalian cells. In an attempt to find a cure for African sleeping sickness, a lethal disease caused by a human pathogen, Trypanosoma brucei, nucleotide metabolism of the parasite was studied. The trypanosomes exhibit strikingly low CTP pools compared with mammalian cells and they also lack salvage of cytidine/cytosine making the parasite CTP synthetase a potential target for treatment of the disease. Following expression, purification and kinetic studies of the recombinant T. brucei CTP synthetase it was found that the enzyme has a higher Km value for UTP than the mammalian CTP synthetase. In combination with a lower UTP pool the high Km may account for the low CTP pool in trypanosomes. The activity of the trypanosome CTP synthetase was irreversibly inhibited by the glutamine analog acivicin, a drug extensively tested as an antitumor agent. Daily injections of acivicin to trypanosome-infected mice were sufficient to suppress the parasite infections. The drug was shown to be trypanocidal when added to cultured bloodstream T. brucei for four days at 1 uM concentration. Therefore, acivicin may qualify as a drug with “desirable” properties, i.e. cure within 7 days, according to the current Target Product Profiles of WHO and DNDi. Trypanosomes lack de novo purine biosynthesis and are therefore dependent on exogenous purines such as adenosine that is taken up from the blood by high-affinity transporters. We found that besides the cleavage-dependent pathway, where adenosine is converted to adenine by inosine-adenosine-guanosine-nucleoside hydrolase, T. brucei can also salvage adenosine by adenosine kinase (AK). The efficient adenosine transport combined with a high-affinity AK yields a strong salvage system in T. brucei, but on the other hand makes the parasites highly sensitive to adenosine analogs such as adenine arabinoside (Ara-A). The cleavage-resistant Ara-A was shown to be readily taken up by the parasites and phosphorylated by the TbAK-dependent pathway, inhibiting trypanosome proliferation and survival by incorporation into nucleic acids and by affecting nucleotide levels in the parasite.

Combined atomic force microscopy-scanning electrochemical microscopy (AFM-SECM) is capable of providing simultaneous topographical and electrochemical imaging at sample surfaces. Integration of amperometric biosensors at tip-integrated electrodes recessed from the apex of the AFM tip further enhances the versatility of such bifunctional probes. Of particular interest to this work was the detection of adenosine triphosphate (ATP) at a cellular level, since ATP is involved in many biologically relevant processes. There are challenges concerning the integration of biosensors into bifunctional AFM-SECM probes. This thesis focuses on addressing and advancing several of these limitations. Thin insulation layers are important for AFM-SECM based applications to enhance AFM and SECM performance. Plasma-polymerized fluorocarbon membranes are introduced as novel thin film insulation materials for AFM-SECM probes. Insulation layers with a thickness of < 300 nm were found to exhibit excellent insulating properties and satisfying temporal stability for successful application in AFM-SECM experiments. Furthermore new approaches for increasing the electrode area in conventionally focused ion beam (FIB) fabricated AFM-SECM probes were implemented, since enhancement of the current response in conjunction with biosensing experiments is required. Ion beam induced deposition (IBID) was used to generate platinum carbon (PtC) deposits at AFM-SECM probes, thereby successfully increasing the tip-integrated electrode area. PtC composites were thoroughly characterized in terms of their physical and electrochemical properties. Since a high carbon fraction in the PtC composite was inhibiting the charge transfer kinetics at the electrode surface for certain analytes, several pre-treatment strategies were investigated including annealing, UV/ozone treatment, and FIB milling. FIB milling proved to be the most promising procedure improving charge transfer properties at the electrode along with fabrication compatibility at AFM-SECM probes. The last part of this thesis aimed at providing fundamental studies on AFM-SECM application at live epithelial cell monolayers. AFM was used in different imaging modes to characterize the topography of epithelial cells. ATP detection at epithelial cells was achieved with amperometric biosensors combined with non-invasive SECM. Biosensors were further miniaturized at batch-fabricated AFM-SECM probes enabling laterally-resolved detection of ATP at epithelial cells. Additionally, PtC composite materials were evaluated for applicability as transducer platforms for enzymatic biosensors.

Η λειτουργική διαφοροποίηση κατά το διαφραγματοκροταφικό άξονα του ιπποκάμπου αφορά και την επιληψία. Χρησιμοποιώντας το μοντέλο ελεύθερο μαγνησίου και δυναμικά πεδίου παρατηρήσαμε πως οι επιληπτόμορφες εκφορτίσεις παρατηρούνταν πιο συχνά, είχαν μεγαλύτερη συχνότητα, διάρκεια και ένταση στις κοιλιακές τομές. Ο ανταγωνιστής των NMDA υποδοχέων AP5 μείωσε τη διάρκεια μόνο στις κοιλιακές τομές. Η προσθήκη του NMDA προκάλεσε εμμένουσες επιληπτόμορφες εκφορτίσεις στο 51% των κοιλιακών και το 9% των ραχιαίων τομών. Προτείνουμε πως οι υποδοχείς NMDA συμμετέχουν στη μεγαλύτερη ευπάθεια του κοιλιακού ιπποκάμπου τόσο στην έκφραση όσο και στη μακρόχρονη διατήρηση των επιληπτόμορφων εκφορτίσεων. Για να μελετήσουμε την επιληπτογένεση με άρση του αδενοσινεργικού τόνου, χρησιμοποιήσαμε πρωτόκολλα εκλεκτικού ή μη αποκλεισμού των αδενοσινεργικών υποδοχέων σε συνθήκες ελεύθερες μαγνησίου και καταγράψαμε αυθόρμητα ή προκλητά δυναμικά πεδίου στη CA3 σε κοιλιακές και ραχιαίες τομές. O αποκλεισμός του Α1 προκάλεσε επιληπτογένεση στο 31,13% των ραχιαίων και στο 52,76% των κοιλιακών τομών (P<0,05). Ο σύγχρονος αποκλεισμός του NMDA υποδοχέα αύξησε τα ποσοστά επιληπτογένεσης και στους δυο πόλους (76,38% στις ραχιαίες τομές vs 80,68% στις κοιλιακές τομές). Αυτή η NMDA-ανεξάρτητη επιληπτογένεση μειώθηκε σημαντικά με την προσθήκη του ανταγωνιστή των Α2 υποδοχέων κυρίως στις ραχιαίες τομές. O αποκλεισμός του Α1 υποδοχέα σε συνθήκες αποκλεισμού των NMDA υποδοχέων προκάλεσε παρόμοια αύξηση της κλίσης του fEPSP στις ραχιαίες τομές και στις κοιλιακές τομές. Ο επιπλέον αποκλεισμός των Α2 υποδοχέων επανέφερε την κλίση του fEPSP στο αρχικό της μέγεθος μόνο στις ραχιαίες τομές. Ο σύγχρονος αποκλεισμός των Α1 και Α2 υποδοχέων προκάλεσε επιληπτογένεση πρακτικά μόνο στις κοιλιακές τομές. H επιληπτογένεση αυτή ήταν μερικώς NMDA-εξαρτώμενη. Επιπλέον ενώ ο αποκλεισμός του Α1 προκάλεσε αύξηση της επιφάνειας της καμπύλης του fEPSP σε συνθήκες ελεύθερες μαγνησίου μόνο στις ραχιαίες τομές (96,15%), ο σύγχρονος αποκλεισμός των Α1 και Α2 υποδοχέων προκάλεσε αύξηση κατά 196,62% στις ραχιαίες τομές και 105,26% στις κοιλιακές τομές. Συμπεραίνουμε πως ο εκλεκτικός ή μη αποκλεισμός των υποδοχέων της αδενοσίνης προκαλεί διαφορετικά είδη επιληπτογένεσης που οφείλονται στις διαφορετικές δράσεις των υποδοχέων της αδενοσίνης και την ικανότητα του κοιλιακού ιπποκάμπου για ΝMDA-εξαρτώμενη επιληπτογένεση Χρησιμοποιώντας δυναμικά πεδίου σε κοιλιακές τομές και δυο μοντέλα επιληπτογένεσης παρατηρήσαμε πως οι σχετιζόμενες με τις επιληπτόμορφες εκφορτίσεις υψίσυχνες ταλαντώσεις και η διεγερτική νευροδιαβίβαση συμμεταβάλονται κατά τη διάρκεια της επιληπτογένεσης Παθολογικές υψίσυχνες ταλαντώσεις παρατηρήθηκαν πάντα στην NMDA-εξαρτημένη αλλά όχι και την NMDA-ανεξάρτητη επιληπτογένεση. Η διάρκεια των υψίσυχνων ταλαντώσεων συσχετίστηκε με τη διάρκεια των μεσοκριτικών εκφορτίσεων μόνο μετά την επαγωγή της επιληπτογένεσης Χρησιμοποιώντας ερεθισμό 100Hz και αυξημένη συγκέντρωση καλίου επάγαμε LTP με ερεθισμό των παράπλευρων κλάδων στη CA3 σε συνθήκες αποκλεισμού των υποδοχέων NMDA. Ο νέος τύπος του NMDA-ανεξάρτητου αυτού LTP παρουσίασε αργή ανάπτυξη στο χρόνο, δε μετέβαλε τη διευκόλυνση με σύζευξη παλμών και δεν επαγόταν με ταυτόχρονο αποκλεισμό των ευαίσθητων στη νιφεδιπίνη διαύλων ασβεστίου. Το μέγεθος του LTP ήταν σημαντικά μεγαλύτερο στις ραχιαίες τομές σε σχέση με τις κοιλιακές. / Functional segregation along the dorso-ventral axis of the hippocampus refers to epilepsy too. Using the model of magnesium-free medium and field recordings, single epileptiform discharges displayed higher incidence, rate, duration and intensity in ventral compared with dorsal rat hippocampal slices. The NMDA receptor antagonist AP5 shortened the discharges in ventral slices only. At 5 and 10μΜ of NMDA application 51% of the ventral but only 9% of the dorsal slices displayed persistent epileptiform discharges. We propose that the NMDA receptors contribute to the higher susceptibility of the ventral hippocampus to expression and long-term maintenance of epileptiform discharges. To study epileptogenesis following withdrawal of adenosinergic tone we used models of selective or non-selective blockade of adenosine receptors in magnesium-free medium and we recorded spontaneous or evoked field potentials in CA3 in dorsal as well as ventral slices. Blockade of A1 resulted in epileptogenesis in 31,13% of dorsal and in 52,76% of ventral slices used (P<0,05). NMDAR blockade increased epileptogenesis scores in both poles (76,38% in dorsal slices vs 80,68% in ventral slices). This NMDAR-dependent epileptogenesis was significantly aborted by blockade of A2R more in dorsal slices. Blockade of A1R under conditions of NMDAR blockade resulted to a similar increase of fEPSP slope in dorsal and ventral slices. The additional blockade of A2R decreased fEPSP slope to its original value in dorsal slices only. Simultaneous blockade of A1 and A2 receptors induced epileptogenesis practically in ventral slices only. This epileptogenesis was partially NMDA-dependent. Futrhermore A1R blockade resulted to an increase of fEPSP area under conditions of magnesium-free medium in dorsal slices only, whereas simultaneous blockade of both A1 and A2 receptors to an increase by 196,62% in dorsal slices and by 105,26% in ventral slices. We conclude that the selective or not blockade of adenosine receptors induces different kinds of epileptogenesis and this can be attributed to the different actions of adenosine receptors and the capability of ventral hippocampus to support NMDA-dependent epileptogenesis Employing field recordings from ventral hippocampal slices and two models of epileptogenesis, we found that HFOs associated with epileptiform bursts and excitatory synaptic transmission were co-modulated during epileptogenesis Pathological HFOs>200Hz were unequivocally present in persistent bursts induced by NMDA receptor-dependent but not NMDA receptor-independent mechanisms. The duration of pathological HFOs associated with persistent bursts but not of HFOs associated with bursts before the establishment of epileptogenesis was linearly and strongly correlated with the duration of bursts. Using 100Hz trains and medium with a higher concentration of potassium cations we induced LTP by stimulating associational/commissural fibers in CA3 region under conditions of NMDA receptor blockade. This new type of NMDAR-independent LTP displayed slow kinetics, did not change paired pulse facilitation and was prevented by simultaneous blockade of nifedipine-sensitive calcium channels. The incidence as well as the amplitude of LTP was greater in dorsal slices compared to ventral ones.

PKCe plays a very important role in mediating the protection against myocardial ischemia and reperfusion injury induced by ischemic preconditioning (IPC) and pharmacologic preconditioning (PPC). The redistribution of PKCe was assessed by subcellular fractionation and western blotting in the Langendorff-perfused rabbit heart. Either 5min ischemia or 5min administration of adenosine A1 and/or A3 agonists, bradykinin, angiotensin II, and d1-opioid agonists resulted in PKCe redistribution from the cytosol to the mitochondria. This effect of IPC on PKCe redistribution was visible up to at least 30min of reperfusion, while that of PPC was lost by 10min of drug washout, indicative of the transient nature of PKCe redistribution. PKCe redistribution to mitochondria by IPC was also visualized using immunogold electron microscopy. Thus, IPC and PPC caused PKCe redistribution from the cytosol to the mitochondria, which was longer-lasting in IPC than in PPC.